Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for synthesizing ritodrine hydrochloride

A technique for synthesizing ritodrine hydrochloride, which is applied in the fields of chemical instruments and methods, preparation of organic compounds, preparation of aminohydroxyl compounds, etc., can solve problems such as complicated process and achirality of ritodrine, and achieve simple process flow, The effect of cost reduction and low price

Inactive Publication Date: 2018-01-05
武汉茵茂特生物技术有限公司
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, there are many reports on the preparation methods of ritodrine, most of which firstly prepare α-bromo-4-hydroxypropiophenone through the bromination reaction of 4-hydroxypropiophenone, and then through amination with p-hydroxyphenylethylamine in turn. And the selective reduction of carbonyl is also prepared, but its process is complex, and most of the synthesized ritodrine is achiral

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for synthesizing ritodrine hydrochloride
  • Method for synthesizing ritodrine hydrochloride
  • Method for synthesizing ritodrine hydrochloride

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] The whole cell of genetically engineered bacteria derived from Zymomonas mobilis phenylacetone synthase is prepared by selecting the gene sequence of phenylacetone synthase derived from Zymomonas mobilis and artificially designing it. The designed gene sequence is as SEQ ID NO in the sequence table : The nucleotide sequence shown in 1 is shown in the sequence; the sequence is synthesized by the whole gene, cloned into the Nde I and Xho I restriction sites of the expression vector pET28a, and transformed into competent cells of the host bacteria E.coli BL21(DE3); After picking the positive transformants and sequencing for identification, a recombinant expression vector is obtained; the recombinant expression vector is transferred into E.coli BL21(DE3) strain to obtain a recombinant phenylacetone synthase genetically engineered strain that can induce expression of recombinant phenylacetone synthase. The recombinant phenylacetone synthase genetically engineered bacteria was ...

Embodiment 2

[0036] The reaction system is composed of p-chlorobenzaldehyde compound of formula II and pyruvate compound of formula III as substrates and buffer solution, catalyst and additives are added, reacted and purified to obtain compound of formula IV (R)-1-(4-chlorophenyl) -1-Hydroxypropan-2-one.

[0037] The specific reaction process is as follows: the reaction is carried out in a 1L shake flask, the reaction system is controlled to 300mL, and the compound of formula II p-chlorobenzaldehyde (29.51g, 0.21mol) and the compound of formula III pyruvic acid (24.64g, 0.28mol) are used as substrates. , Using citric acid-sodium citrate buffer solution as solvent, using genetically engineered bacteria whole cells derived from Zymomonas mobilis phenylacetone synthase and coenzyme thiamine pyrophosphate as catalyst. Control the concentration of whole cells of genetically engineered bacteria derived from Zymomonas mobilis phenylacetone synthase to 100g / L, and control the concentration of coenzym...

Embodiment 3

[0041] Take formula IV compound (R)-1-(4-chlorophenyl)-1-hydroxypropan-2-one and ammonium formate as substrates, form a reaction system with buffer solution, add catalyst, react, and purify to obtain formula V The compound (1R, 2S)-2-amino-1-(4-chlorophenyl)-1-propanol.

[0042] The reaction was carried out in a 1L shake flask, the reaction system was controlled to 300 mL, and the compound of formula IV (R)-1-(4-chlorophenyl)-1-hydroxypropan-2-one (35.06g, 0.19mol) and ammonium formate (23.94g, 0.38mol) as the substrate, the phosphate buffer solution as the solvent, the genetically engineered bacterial fragmentation enzyme solution of leucine dehydrogenase derived from Saccharomyces cerevisiae, the gene of formate dehydrogenase derived from Candida boidinii Engineering bacteria cell crushing enzyme solution and coenzyme NAD+ are catalysts. Control the concentration of the disrupted enzyme solution of genetically engineered bacteria derived from Saccharomyces cerevisiae to 10g / L,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for synthesizing ritodrine hydrochloride. The method comprises that p-chlorobenzaldehyde and pyruvic acid as substrates undergo a catalytic reaction, the product is purified to form (R)-1-(4-chlorophenyl)-1-hydroxypropane-2-one, the (R)-1-(4-chlorophenyl)-1-hydroxypropane-2-one and ammonium formate as substrates undergo a catalytic reaction, the product is purifiedto form (1R, 2S)-2-amino-1-(4-chlorophenyl)-1-propanol, the (1R, 2S)-2-amino-1-(4-chlorophenyl)-1-propanol and LiOH. H2O undergo a reaction to produce 4-((1R, 2S)-2-amino-1-hydroxypropyl)phenol and 4-((1R, 2S)-2-amino-1-hydroxypropyl)phenol and 4-(2-chloroethanol)phenol undergo a reaction to produce ritodrine hydrochloride. The method realizes a low cost, utilizes mild reaction conditions and issuitable for industrial production.

Description

Technical field [0001] The invention relates to a method for preparing raw materials and pharmaceutical intermediates, in particular to a method for synthesizing ritodrine hydrochloride. Background technique [0002] Litojun is a beta developed by Solvay in Belgium 2 Adrenergic receptor agonist, first marketed in Sweden in 1973. Litodrine can stimulate the β of uterine smooth muscle 2 The receptor inhibits the frequency, intensity and duration of uterine smooth muscle contraction, thereby prolonging the pregnancy period and increasing the maturity of the fetal heart and lungs, which is beneficial to the health of the baby. It is used for anti-premature delivery treatment for pregnant women over 20 weeks of pregnancy. [0003] At present, there have been many reports on the preparation method of ritodrine, most of which are the first preparation of α-bromo-4-hydroxypropiophenone by the bromination reaction of 4-hydroxypropiophenone, and then the aminating with p-hydroxyphenethylamin...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07C215/60C07C213/02C07C213/08C12P13/00
Inventor 胡磊奚超群彭丹
Owner 武汉茵茂特生物技术有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products